Home COVID-19 Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients

Tuesday, April 7, 2020

Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients

COVID-19
Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients submitted by /u/genericdude999
[link] [comments]

Artikel Terkait

Influenza antiviral Avigan® (favipiravir) to enter Phase III trials in COVID-19 patients
4/ 5
Oleh
Komentar

Berlangganan

Suka dengan artikel di atas? Silakan berlangganan gratis via email


EmoticonEmoticon